News

Published on 7 Apr 2022 on Benzinga

23 Stocks Moving in Thursday's Pre-Market Session


Article preview image

Don’t forget to check out our premarket coverage here .

NYSE.IRNT price evolution
NASDAQ.ERYP price evolution
NASDAQ.GNUS price evolution
NASDAQ.LEDS price evolution
NYSE.EURN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Erytech's Battle With Activist Investor Echoes As Pherecydes Pharma Merger Vote Comes Closer

In February, Erytech Pharma SA (NASDAQ: ERYP) announced its proposed combination with Pherecydes ...

Benzinga via Yahoo Finance 13 Jun 2023

Erytech Pharma SA Sponsored ADR (ERYP) Upgraded to Buy: Here's Why

Erytech Pharma SA Sponsored ADR (ERYP) could be a solid choice for investors given its recent upg...

Zacks via Yahoo Finance 5 Oct 2022

Erytech (ERYP) Stops Developing Drug in Leukemia, Down 19.6%

Shares of Erytech Pharma ERYP fell 19.6% on Aug 25 after management announced that it would no lo...

Zacks via Yahoo Finance 26 Aug 2022

Erytech Pharma Culls Work On Late-Stage Leukemia Asset, Evaluates Partnership Options

Erytech Pharma SA (NASDAQ: ERYP) will no longer seek approval for Graspa in hypersensitive acute ...

Benzinga via Yahoo Finance 25 Aug 2022

Catalent Shares Jump As Investors Cheer Revised, Better Than Expected FY22 Outlook

View more earnings on CTLT See more from Benzinga

Benzinga via Yahoo Finance 30 Jul 2022

3 Reasons to Retain Catalent (CTLT) Stock in Your Portfolio

Catalent, Inc. CTLT is well-poised for growth in the coming quarters, backed by its robust facili...

Zacks via Yahoo Finance 29 Jun 2022

Reasons to Retain Catalent (CTLT) Stock in Your Portfolio

Catalent, Inc. CTLT is well-poised for growth in the coming quarters, backed by its robust facili...

Zacks via Yahoo Finance 23 May 2022

Catalent's (CTLT) Latest Facility Expansion to Boost Capacity

Catalent, Inc. CTLT announced that it commenced a $175-million project to expand its flagship U.S...

Zacks via Yahoo Finance 23 May 2022

Catalent's (CTLT) New Launch to Enhance Gene Therapy Development

Catalent, Inc. CTLT has recently introduced its new UpTempo Virtuoso platform process. The platfo...

Zacks via Yahoo Finance 19 May 2022

71 Biggest Movers From Yesterday

Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA gran...

Benzinga 27 Apr 2022